Best Probiotics for Celiac Disease and Gluten Sensitivity: What the Evidence Actually Shows
A research-backed look at which probiotic strains support gut health alongside a gluten-free diet
If you have celiac disease or non-celiac gluten sensitivity, you already know that a strict gluten-free diet (GFD) is the cornerstone of management. But an emerging body of research is revealing something important: for many people, a gluten-free diet alone is not enough to fully restore the gut ecosystem that gluten has disrupted.
Studies show that even after years of strict GFD adherence, celiac patients frequently continue to experience gut dysbiosis—an imbalance in the gut microbiome characterized by reduced populations of beneficial bacteria and elevated levels of potentially pro-inflammatory species.[1] The result: residual symptoms including fatigue, bloating, and abdominal discomfort that persist even without active gluten exposure.
Probiotics are increasingly recognized as a meaningful adjunct to the GFD for celiac disease and gluten sensitivity—not as a replacement for dietary vigilance, but as a tool for addressing the microbiome imbalances that the diet alone cannot fully correct. This guide examines the peer-reviewed clinical evidence behind specific probiotic strains relevant to celiac disease and gluten sensitivity, with a particular focus on their mechanisms and what the research actually demonstrates.
Key Takeaways
- Gut dysbiosis persists in celiac disease even on a strict GFD. Research consistently finds lower abundances of beneficial Lactobacillus and Bifidobacterium species and higher levels of pro-inflammatory bacteria in untreated and treated celiac patients compared to healthy controls.[1]
- Multi-strain Lactobacillus and Bifidobacterium combinations can hydrolyze immunogenic gliadin peptides. A 2024 study in Nutrients confirmed that peptidase preparations from L. casei, L. paracasei, and Streptococcus thermophilus significantly reduced the immunoreactivity of gliadin peptides—including the toxic 33-mer fragment—with effects markedly greater when strains were used in combination.[2]
- Probiotics can improve gastrointestinal symptoms in celiac patients. A 2023 systematic review and meta-analysis concluded that probiotics may improve GI symptoms in patients with celiac disease on a GFD.[3]
- Bifidobacterium longum supplementation in newly diagnosed celiac children significantly reduced pro-inflammatory markers in a double-blind, randomized, placebo-controlled trial, improving health status even on a GFD.[4]
- A multi-strain formula is critical. Research has demonstrated that individual probiotic strains cannot degrade gliadin peptides on their own—the synergistic combination of multiple strains is required for meaningful gluten hydrolysis activity.[5]
- Prebiotic support enhances probiotic effectiveness. Inulin-type prebiotics given to celiac patients on a GFD significantly increased Bifidobacterium counts and raised beneficial SCFA levels, suggesting prebiotics compound the benefit of probiotic supplementation.[6]
The Microbiome in Celiac Disease and Gluten Sensitivity
Celiac disease (CD) is a chronic autoimmune enteropathy triggered by gluten ingestion in genetically predisposed individuals. Beyond the well-documented immune reaction and intestinal villous damage, research has increasingly focused on a third dimension: the role of the gut microbiome in both the pathogenesis of celiac disease and the persistence of symptoms after diagnosis.
The Dysbiosis Pattern in Celiac Disease
Multiple studies have identified a consistent microbial signature in celiac patients. Compared to healthy individuals, untreated celiac patients show a measurably reduced abundance of beneficial bacteria—particularly Lactobacillus and Bifidobacterium species—and an elevated presence of potentially pro-inflammatory genera including certain Bacteroides and Escherichia coli strains.[1] This dysbiosis is not simply a consequence of intestinal damage; evidence suggests it contributes to the perpetuation of immune activation and increased intestinal permeability, the "leaky gut" phenomenon that allows gliadin fragments to enter the lamina propria and sustain inflammation.[7]
A GFD Alone May Not Fully Restore Microbiome Balance
A 2024 review in Annals of Gastroenterology noted that dysbiosis in celiac disease persists across various disease stages and is only partially corrected by a gluten-free diet.[1] Strict GFD adherence reduces dietary fiber diversity and may deplete beneficial microbiota populations further over time—yet another reason why proactive microbiome support merits attention.
Gluten Sensitivity and the Microbiome
Non-celiac gluten sensitivity (NCGS) presents its own microbial profile. Research shows NCGS patients exhibit a notable decrease in overall microbial richness relative to both healthy controls and celiac patients, with altered ratios of Ruminococcaceae and Bacteroidetes.[1] The practical implication for both conditions is that restoring and maintaining diverse, beneficial bacterial populations through probiotic and prebiotic strategies represents a legitimate and scientifically grounded complementary approach—always alongside, and never replacing, dietary management.
Why Gut Bacteria Matter for Gluten Metabolism
The gut microbiota's role extends beyond general health maintenance—specific bacterial species participate directly in the digestion of dietary proteins, including gluten. Certain Lactobacillus and Bifidobacterium strains produce proteolytic enzymes capable of breaking down proline-rich gliadin peptides that human digestive enzymes cannot fully process.[8] Research has demonstrated that a reduction in these beneficial species—exactly what is observed in celiac patients—could impair the gut's capacity for partial gluten detoxification, potentially amplifying immune reactivity to even trace gluten exposure.
This microbiome-gluten connection creates a compelling rationale for targeted probiotic supplementation: not to cure celiac disease, but to help restore the bacterial populations whose activity supports a more resilient and balanced gut environment. For a deeper dive into what Bifidobacterium deficiency looks like and why it matters for gut health broadly, the evidence points in a consistent direction.
How Probiotics Support Gut Health in Celiac Disease and Gluten Sensitivity
The mechanisms through which probiotics may benefit people with celiac disease and gluten sensitivity operate across several interconnected pathways. Understanding these mechanisms helps clarify why multi-strain formulations—rather than single-strain products—show the most consistent results in the research.
1. Gliadin Peptide Hydrolysis
One of the most studied mechanisms is direct enzymatic degradation of gluten-derived peptides. The toxic 33-mer α-gliadin peptide is one of the most immunodominant fragments driving celiac disease pathology—it is highly resistant to digestion by human gastrointestinal enzymes. However, certain probiotic bacteria produce peptidases capable of hydrolyzing this fragment and reducing its immunogenic potential.
Landmark research by De Angelis and colleagues demonstrated that the multi-strain probiotic preparation VSL#3—containing Bifidobacterium breve, B. infantis, B. longum, Lactobacillus plantarum, L. acidophilus, L. casei, L. delbrueckii subsp. bulgaricus, and Streptococcus thermophilus—was highly effective at hydrolyzing gliadin polypeptides during sourdough fermentation. Critically, exposure of celiac jejunal biopsies to the fermented product did not trigger the normal infiltration of CD3+ intraepithelial lymphocytes, suggesting meaningful detoxification.[5] The same research demonstrated that single probiotic strains tested in isolation were unable to reproduce this effect—the synergistic activity of multiple strains was essential.
The 2024 Gliadin Immunoreactivity Study
A study published in Nutrients in 2024 evaluated the ability of selected probiotic strains to hydrolyze immunoreactive gliadin peptides. Peptidase preparations from Lacticaseibacillus casei, Lacticaseibacillus paracasei, and Streptococcus thermophilus significantly reduced gliadin immunoreactivity—including the clinically critical 33-mer fragment. The researchers also identified peptidase-encoding genes in the genomes of L. casei and L. paracasei with the capacity to hydrolyze proline-rich peptide bonds, and confirmed that combined strain use produced effects markedly superior to individual strains tested alone.[2]
2. Intestinal Barrier Support
In celiac disease, gliadin triggers zonulin release—a paracrine hormone that disassembles tight junctions between intestinal epithelial cells, creating the increased intestinal permeability characteristic of the condition.[7] Specific probiotic strains have been shown to support tight junction integrity through complementary mechanisms.
Research on Caco-2 epithelial cell models demonstrated that Bifidobacterium lactis could inhibit the gliadin-induced increase in epithelial permeability in a dose-dependent manner.[7] Lactobacillus rhamnosus has been shown to sustain the expression of intercellular junction proteins, counteracting gliadin-driven permeability increases. Probiotic support for intestinal barrier repair represents one of the most active areas of celiac-adjacent research, with both Lactobacillus and Bifidobacterium strains demonstrating protective effects on the gut lining.
3. Immune Modulation
The immune dysregulation in celiac disease—characterized by elevated pro-inflammatory cytokines including TNF-α and IFN-γ—is a therapeutic target that several probiotic strains have been shown to influence. Bifidobacterium longum and Bifidobacterium bifidum strains have been investigated in vitro for their ability to restore the proinflammatory cytokine profile in celiac-associated conditions, demonstrating lower production of TNF-α and IFN-γ when challenged with gliadin.[9] A randomized controlled trial in children with celiac disease found that Bifidobacterium breve supplementation resulted in a significant reduction in TNF-α levels over the three-month intervention period.[10]
4. Microbiome Restoration
Beyond specific mechanisms, probiotic supplementation in celiac patients has been shown to shift the overall microbial composition toward a healthier profile. A double-blind, placebo-controlled trial found that probiotic administration in celiac patients on a GFD improved clinical symptoms—including a significant reduction in fatigue scores (P = 0.02)—while increasing the relative abundance of Lactobacillus spp., Bifidobacterium spp., and other beneficial populations compared to the placebo group.[11]
Best Probiotic Strains for Celiac Disease and Gluten Sensitivity
The most clinically relevant probiotic strains for celiac disease and gluten sensitivity fall into four genera: Lactobacillus, Bifidobacterium, Streptococcus, and spore-forming Bacillus. Each contributes different mechanisms, and the emerging consensus from the research is that combinations consistently outperform individual strains.
Lactobacillus plantarum
Lactobacillus plantarum is among the most extensively studied strains for gliadin degradation. Cell extracts from L. plantarum strains have demonstrated hydrolysis of α-gliadin fragments in vitro, and this species has been consistently represented in the multi-strain combinations showing the strongest gluten-detoxifying activity.[8] Its robust proteolytic system and well-documented ability to reinforce intestinal barrier integrity through mucin upregulation make it a cornerstone strain for celiac-related support. For a comprehensive look at its broader evidence base, see our detailed article on Lactobacillus plantarum health benefits.
Lactobacillus casei and Lactobacillus paracasei
These closely related strains have emerged as particularly promising candidates for gliadin hydrolysis. The 2024 Nutrients study confirmed that peptidase preparations from L. casei and L. paracasei significantly reduced gliadin immunoreactivity including the critical 33-mer peptide, with in silico genome analysis identifying specific peptidase-encoding genes with proline-hydrolyzing capacity.[2] Earlier research also demonstrated that sourdough strains of L. casei could individually metabolize the 33-mer peptide—a finding with direct relevance to celiac disease pathogenesis.
Streptococcus thermophilus
Though less frequently spotlighted than Lactobacillus species, Streptococcus thermophilus plays an important supporting role in gluten peptide reduction. The same 2024 study confirmed that S. thermophilus contributed meaningfully to gliadin immunoreactivity reduction when combined with L. casei and L. paracasei—a synergistic effect exceeding what any strain accomplished individually.[2] This strain also appeared in the VSL#3 combination that demonstrated celiac biopsy-level non-reactivity in De Angelis et al.'s research.[5] Learn more about this strain in our article on Streptococcus thermophilus benefits.
Bifidobacterium longum
Longitudinal data from the PNAS CDGEMM cohort identified higher abundances of B. longum in infants who remained healthy compared to those who subsequently developed celiac disease, with the species showing protective effects on inflammatory cytokine production in gliadin-challenged animal models.[12] In clinical application, a double-blind, randomized, placebo-controlled trial in 33 children with newly diagnosed celiac disease demonstrated that B. longum CECT 7347 supplementation significantly reduced the number of Bacteroides fragilis and lowered secretory IgA levels in stool compared to placebo—evidence of meaningful immune and microbial modulation.[4] For food sources and supplementation context, see our guide to Bifidobacterium longum in food.
Bifidobacterium breve
A double-blind, placebo-controlled RCT in 40 celiac children using a two-strain Bifidobacterium breve formulation (BR03 and B632) demonstrated that probiotic administration produced a significant reduction in TNF-α—a key pro-inflammatory cytokine elevated in active celiac disease—while also modulating short-chain fatty acid profiles.[10] Research from the Frontiers in Medical Technology celiac microbiome review also confirmed that B. breve supplementation modulated SCFA production and acetic acid levels, contributing to microbiome restoration in treated celiac patients.[13]
Bifidobacterium lactis
As noted above, B. lactis has demonstrated the capacity to block gliadin-induced increases in intestinal epithelial permeability in dose-dependent in vitro research.[7] This barrier-protective mechanism is particularly relevant in the celiac context where gliadin directly disrupts tight junctions. A 2025 prospective, double-blind, randomized placebo-controlled trial involving celiac patients also included B. lactis (alongside L. rhamnosus) in the intervention group, with the probiotic blend associated with improved gastrointestinal symptoms over 90 days.[14]
Lactobacillus rhamnosus
Lactobacillus rhamnosus has well-established intestinal permeability benefits: preclinical research confirmed this strain sustains intercellular junction protein expression against gliadin-driven permeability increases.[7] It has also been included in celiac-focused clinical trials demonstrating GI symptom improvement. The broader evidence base for this strain is substantial—our detailed article on Lactobacillus rhamnosus benefits covers the clinical depth in full.
Lactobacillus acidophilus
L. acidophilus is a founding member of the multi-strain combinations studied for gliadin detoxification, including the VSL#3 preparation that demonstrated reduced CD biopsy reactivity.[5] It also appears in the Oxadrop probiotic combination that has been evaluated for celiac disease management. Its broad mucosal health benefits and bacteriocin production (lactacin B) contribute to competitive exclusion of pathogenic bacteria—an important consideration given the elevated pro-inflammatory bacterial counts seen in celiac patients. See the full evidence summary in our article on Lactobacillus acidophilus benefits.
Bacillus coagulans and Bacillus subtilis
Spore-forming Bacillus strains offer unique advantages for celiac and gluten-sensitive individuals: their spore form provides exceptional stability and survival through gastric acid, ensuring viable bacteria reach the small intestine where gliadin metabolism is most relevant. Research on novel probiotic preparations for gluten degradation has specifically included Bacillus species alongside lactobacilli, recognizing their complementary proteolytic mechanisms and resilience in the harsh upper gastrointestinal environment.[15]
The evidence is clear on one point: no single strain is sufficient for meaningful gliadin hydrolysis or comprehensive microbiome restoration. The multi-strain principle that emerges from the research directly informs what to look for in a supplement.
| Strain | Key Mechanism | Evidence Highlight |
|---|---|---|
| L. plantarum | Gliadin hydrolysis, barrier support | Hydrolyzed 73% of α-gliadin fragments in vitro; barrier reinforcement via mucin upregulation[8] |
| L. casei / L. paracasei | Gliadin peptide immunoreactivity reduction | Significantly reduced 33-mer immunoreactivity; peptidase genes identified (2024)[2] |
| S. thermophilus | Synergistic gliadin hydrolysis | Multi-strain combination reduced gliadin immunoreactivity; no CD3+ lymphocyte infiltration in biopsy[5] |
| B. longum | Immune modulation, microbiome normalization | Reduced B. fragilis and sIgA in celiac children RCT (double-blind)[4] |
| B. breve | TNF-α reduction, SCFA modulation | Significant TNF-α reduction in celiac children RCT[10] |
| B. lactis | Intestinal permeability protection | Dose-dependent inhibition of gliadin-induced epithelial permeability increase[7] |
| L. rhamnosus | Tight junction support, immune balance | Sustained junction protein expression against gliadin; improved GI symptoms in celiac RCT[14] |
| L. acidophilus | Competitive exclusion, gliadin hydrolysis | Core strain in VSL#3 demonstrating celiac biopsy non-reactivity[5] |
These Strains, Together, in One Formula
MicroBiome Restore contains all of the above strains—plus 18 more evidence-backed species—in a single daily serving. No microcrystalline cellulose. No magnesium stearate. No titanium dioxide. Just 26 strains, 15 billion CFU, and 9 organic prebiotics in a clean pullulan capsule.
The Role of Prebiotics Alongside Probiotic Support
Probiotics and prebiotics work synergistically—probiotics introduce beneficial bacteria, while prebiotics provide the substrate those bacteria need to thrive and produce beneficial metabolites. This synergistic relationship is particularly relevant in celiac disease, where GFD adherence often reduces dietary fiber diversity and may inadvertently limit the fuel supply for gut-protective bacteria.
Inulin and Celiac Disease: Clinical Evidence
A randomized, placebo-controlled trial in celiac children on a GFD evaluated the effects of oligofructose-enriched inulin supplementation over three months. After the intervention, participants in the prebiotic group showed a significant increase in fecal Bifidobacterium counts—exactly the beneficial genus that celiac patients characteristically lack—along with elevated levels of acetate and butyrate. These short-chain fatty acids (SCFAs) are metabolic byproducts of beneficial bacterial fermentation with direct gut barrier-supportive and anti-inflammatory effects.[6]
Jerusalem artichoke is among the richest natural sources of inulin-type fructans and has been specifically studied for its prebiotic effects on gut microbiome diversity. Our detailed article on Jerusalem artichoke as a prebiotic inulin source covers the mechanism and evidence in depth.
Acacia Fiber for Sensitive Gut Systems
People with celiac disease often have highly sensitive digestive systems—especially those recently diagnosed or still in recovery. Acacia fiber (from Acacia senegal) is a soluble, low-FODMAP prebiotic fiber with a particularly gentle fermentation profile that selectively promotes Bifidobacterium and Lactobacillus growth without triggering the aggressive fermentation and gas production associated with some other prebiotic fibers. This makes it especially well-suited to digestive systems already compromised by intestinal damage. See the evidence for acacia fiber in sensitive gut conditions.
Why GFD Alone May Reduce Your Prebiotic Intake
Traditional gluten-containing grains—wheat, barley, and rye—happen to be significant sources of fructans and other prebiotic fibers in the typical Western diet. When these are removed, many celiac patients inadvertently reduce their total prebiotic intake, which can further deplete gut microbiome diversity over time. A well-formulated synbiotic supplement—one that combines both probiotic strains and prebiotic substrates—addresses this gap directly.
Synbiotic Design for Microbiome Restoration
MicroBiome Restore pairs 26 probiotic strains with 9 organic whole-food prebiotics including Jerusalem artichoke (inulin), acacia fiber, maitake mushroom, bladderwrack, Norwegian kelp, oarweed, and fig fruit—providing a comprehensive prebiotic substrate matrix that feeds and supports the beneficial bacterial populations being introduced. For a complete breakdown of how this formula was built, see our MicroBiome Restore complete guide.
What to Look for in a Probiotic if You Have Celiac Disease or Gluten Sensitivity
Not all probiotic supplements are created equal—and for individuals with celiac disease or gluten sensitivity, the stakes for making the right choice are higher than average. Here are the criteria that matter most based on the research and the specific needs of this population.
Multi-Strain, Not Single-Strain
The research on gliadin hydrolysis is unambiguous: single-strain products cannot degrade immunogenic gluten peptides on their own. The synergistic activity of multiple Lactobacillus, Bifidobacterium, and Streptococcus strains is required for meaningful detoxification activity.[5] A formula covering both lactobacilli (for gliadin hydrolysis and barrier support) and bifidobacteria (for immune modulation and dysbiosis correction) addresses the multiple pathways at play in celiac disease. The evidence firmly supports a multi-strain approach over MCC-filled single-strain options.
Verify the Formula Is Genuinely Gluten-Free
This deserves specific attention: not all commercially available probiotics are free from gluten contamination. A study analyzing top-selling probiotic supplements found that a substantial proportion contained detectable gluten levels—a significant concern for celiac patients. Choose products that are third-party tested and explicitly certified or verified as gluten-free, with transparent manufacturing practices.
Clean Formulation: No Microcrystalline Cellulose, No Magnesium Stearate
The "Other Ingredients" section of a probiotic label deserves as much scrutiny as the active strains, particularly when gut integrity is already compromised. Microcrystalline cellulose (MCC) is a cellulose-derived filler with emerging safety questions for gut mucosal health. Magnesium stearate is a common flow agent with evidence suggesting it can reduce the activity of beneficial gut bacteria. Titanium dioxide—a whitening agent found in many supplements—has been banned as a food additive in the EU. Understanding how to read supplement labels for hidden fillers is a genuinely important skill for the celiac community. A good broader overview of the truth about flow agents and fillers in probiotics should inform every purchase decision.
Capsule Material: Pullulan Over HPMC
Pullulan capsules are fermented, plant-derived, and possess inherent prebiotic properties. Unlike hypromellose (HPMC) capsules—a semi-synthetic polymer—pullulan capsules provide delayed release that helps protect probiotic strains through the acid environment of the stomach. For a full comparison, our article on HPMC vs pullulan capsules lays out the distinction clearly.
Adequate CFU Count With Prebiotic Support
Clinical trials demonstrating meaningful outcomes in celiac-adjacent contexts have used doses ranging from 108 to 1010 CFU across various strain combinations. A multi-strain formula delivering 15 billion CFU (1.5 × 1010) per serving provides a clinically meaningful total count across the full diversity of strains. Combining this with prebiotic support—which helps introduced bacteria establish and thrive—provides a more complete microbiome intervention than probiotic strains alone.
Celiac-Appropriate Probiotic Checklist
Look for: Multi-strain formula with both Lactobacillus and Bifidobacterium genera; explicitly gluten-free verified; no MCC, magnesium stearate, titanium dioxide, or silica; pullulan capsule material; integrated prebiotic support; 10–15+ billion CFU; transparent strain identification.
Be cautious of: Single-strain products; "proprietary blends" that obscure individual strain amounts; supplements without explicit gluten-free verification; formulas relying on MCC as a primary bulking agent; products with no prebiotic component.
An Important Note on Celiac Disease Management
Probiotics are a complementary strategy—they should be used alongside, not instead of, a strict gluten-free diet under the guidance of a healthcare provider. Probiotics are not a treatment for celiac disease and cannot substitute for dietary management. If you are managing celiac disease, work with a gastroenterologist or registered dietitian before adding any supplement to your regimen.
Frequently Asked Questions
Can probiotics cure celiac disease?
No. Celiac disease is a lifelong autoimmune condition for which a strict gluten-free diet remains the only proven treatment. Probiotics cannot cure celiac disease or reverse intestinal damage. What the research does support is that targeted probiotic supplementation—particularly multi-strain formulas containing relevant Lactobacillus and Bifidobacterium species—may help reduce residual GI symptoms, support microbiome restoration, and contribute to improved gut barrier function as an adjunct to the GFD. The evidence for these complementary benefits continues to grow.[3]
Can probiotics break down gluten so I don't have to follow a strict GFD?
No. While certain multi-strain probiotic combinations have demonstrated the ability to hydrolyze some immunogenic gliadin peptides under experimental conditions, this activity is not sufficient to make gluten consumption safe for people with celiac disease. The quantities of gluten in a standard diet far exceed what probiotic bacteria could realistically neutralize. The GFD remains essential—probiotic support is relevant to what happens at the microbial level even in the context of a strict diet.
How long does it take for probiotics to improve symptoms in celiac disease?
Clinical trials in celiac patients have generally used intervention periods of 8–12 weeks, with most measurable changes in microbiome composition and clinical symptoms observed over this timeframe.[11] Individual response varies significantly, and microbiome changes take time. Consistent daily supplementation over at least 8–12 weeks is typically recommended before assessing response. For a broader look at timelines, our article on how long probiotics take to work provides a science-based overview.
Are probiotics safe for people with celiac disease?
In healthy individuals, including those with well-managed celiac disease, probiotics are generally considered safe. The primary safety consideration specific to this population is ensuring the supplement itself is genuinely free from gluten cross-contamination—verified gluten-free certification and transparent manufacturing standards are essential criteria. As with any supplement for a chronic autoimmune condition, consultation with a healthcare provider is recommended before starting.
What is the best probiotic for gluten sensitivity (non-celiac)?
Non-celiac gluten sensitivity (NCGS) has a distinct microbiome signature from celiac disease, but shares the reduced microbial richness and altered bacterial ratios that probiotic supplementation is designed to address.[1] The same multi-strain principles apply: formulas combining Lactobacillus and Bifidobacterium species from the genera shown to support gut barrier function and microbiome diversity are the most evidence-aligned choice. There are no NCGS-specific probiotic trials of the scale conducted for celiac disease, but the mechanistic overlap with celiac disease research provides reasonable clinical justification for multi-strain supplementation.
Should I take a probiotic with or without food if I have celiac disease?
Current evidence on the best time to take probiotics suggests that taking them with or just before a meal—when stomach acid production is naturally buffered by food—improves bacterial survival through the gastrointestinal tract. This is especially relevant for celiac patients whose intestinal environment may already be compromised. Pullulan capsule-based formulas provide additional protection through delayed release. Our full evidence-based guide to the best time to take probiotics covers the research in detail.
Supporting Your Gut While Living Gluten-Free
The science connecting celiac disease and gluten sensitivity to gut microbiome dysbiosis has never been clearer. From the persistence of beneficial bacterial deficits even on a strict GFD, to the demonstrated capacity of specific multi-strain probiotic combinations to hydrolyze immunogenic gliadin peptides and support intestinal barrier integrity—the evidence provides a compelling and scientifically grounded rationale for targeted probiotic supplementation.
The most important conclusion from the research is this: single strains are not enough. The synergistic interplay between multiple Lactobacillus, Bifidobacterium, and Streptococcus species—combined with the barrier and immune modulation effects of spore-forming Bacillus strains—is what produces meaningful outcomes in the clinical literature. A clean formula, free of the gut-disruptive fillers commonly found in commercial supplements, completes the equation.
Alongside a committed gluten-free diet and the guidance of your healthcare team, a well-designed multi-strain synbiotic represents one of the most scientifically supported complementary tools available to those managing celiac disease or gluten sensitivity. Explore how MicroBiome Restore was formulated with these principles in mind—26 strains, 9 organic prebiotics, and a commitment to filler-free formulation in every capsule.
26 Strains. 9 Organic Prebiotics. Zero Fillers.
MicroBiome Restore was built around the science—formulated to deliver the multi-strain diversity the research supports, without the microcrystalline cellulose, magnesium stearate, or titanium dioxide found in most commercial probiotics. Every ingredient has a purpose.
References
- Yemula, N., et al. (2024). Gut microbiota in celiac disease. Annals of Gastroenterology, 37(2), 125–132. https://doi.org/10.20524/aog.2024.0862
- Leszczyńska, J., Szczepankowska, A. K., Majak, I., Mańkowska, D., Smolińska, B., Ścieszka, S., et al. (2024). Reducing immunoreactivity of gluten peptides by probiotic lactic acid bacteria for dietary management of gluten-related diseases. Nutrients, 16(7), 976. https://doi.org/10.3390/nu16070976
- Mozafarybazargany, M., Mohammadian Khonsari, M., Sokoty, L., Ejtahed, H. S., & Qorbani, M. (2023). The effects of probiotics on gastrointestinal symptoms and microbiota in patients with celiac disease: a systematic review and meta-analysis on clinical trials. Clinical and Experimental Medicine, 23(6), 2773–2788. https://doi.org/10.1007/s10238-022-00987-x
- Olivares, M., Castillejo, G., Varea, V., & Sanz, Y. (2014). Double-blind, randomised, placebo-controlled intervention trial to evaluate the effects of Bifidobacterium longum CECT 7347 in children with newly diagnosed coeliac disease. British Journal of Nutrition, 112(1), 30–40. https://doi.org/10.1017/S0007114514000609
- De Angelis, M., et al. (2010). VSL#3 probiotic preparation has the capacity to hydrolyze gliadin polypeptides responsible for celiac sprue probiotics and gluten intolerance. Biochimica et Biophysica Acta — Proteins and Proteomics, 1804(4), 913–922. https://doi.org/10.1016/j.bbapap.2009.12.009
- Drabińska, N., Jarocka-Cyrta, E., Markiewicz, L. H., & Krupa-Kozak, U. (2018). The effect of oligofructose-enriched inulin on faecal bacterial counts and microbiota-associated characteristics in celiac disease children following a gluten-free diet: Results of a randomized, placebo-controlled trial. Nutrients, 10(2), 201. https://doi.org/10.3390/nu10020201
- Zopf, Y., et al. (2024). Intestinal permeability, food antigens and the microbiome: a multifaceted perspective. Frontiers in Allergy, 5, 1505834. https://doi.org/10.3389/falgy.2024.1505834
- Duar, R. M., et al. (2021). Intestinal microbiota and probiotics in celiac disease. Clinical Microbiology Reviews, 34(3), e00105-20. https://doi.org/10.1128/CMR.00105-20
- Medina, M., De Palma, G., Ribes-Koninckx, C., Calabuig, M., & Sanz, Y. (2008). Bifidobacterium strains suppress in vitro the pro-inflammatory milieu triggered by the large intestinal microbiota of coeliac patients. Journal of Inflammation, 5, 19. https://doi.org/10.1186/1476-9255-5-19
- Primec, M., Klemenak, M., Di Gioia, D., Aloisio, I., Cionci, N. B., Quagliariello, A., Gorenjak, M., Mičetić-Turk, D., & Langerholc, T. (2019). Clinical intervention using Bifidobacterium strains in celiac disease children reveals novel microbial modulators of TNF-α and short-chain fatty acids. Clinical Nutrition, 38(3), 1373–1381. https://doi.org/10.1016/j.clnu.2018.06.931
- Soheilian Khorzoghi, M., Rostami-Nejad, A., Yadegar, A., Dabiri, H., Hadadi, A., & Rodrigo, L. (2023). Impact of probiotics on gut microbiota composition and clinical symptoms of coeliac disease patients following gluten-free diet. Clinical Nutrition ESPEN, 57, 643–651. https://doi.org/10.1016/j.clnesp.2023.07.019
- Leonard, M. M., et al. (2021). Microbiome signatures of progression toward celiac disease onset in at-risk children in a longitudinal prospective cohort study. Proceedings of the National Academy of Sciences, 118(29), e2020322118. https://doi.org/10.1073/pnas.2020322118
- Luz, V. C. C., et al. (2024). Celiac disease gut microbiome studies in the third millennium: reviewing the findings and gaps of available literature. Frontiers in Medical Technology, 6, 1413637. https://doi.org/10.3389/fmedt.2024.1413637
- Mattos Boccalini Roston, B. C., et al. (2025). Probiotics as an adjunctive therapy for celiac disease: symptom relief and quality of life improvement. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC12289284/
- Lombardi, A., et al. (2024). Novel probiotic preparation with in vivo gluten-degrading activity and potential modulatory effects on the gut microbiota. PMC Open Access. https://pmc.ncbi.nlm.nih.gov/articles/PMC11218521/
'%3e%3cg%20id='Final-Copy-2_2_'%20transform='translate(1275.000000,%20200.000000)'%3e%3cpath%20class='st0'%20d='M7.4,12.8h6.8l3.1-11.6H7.4C4.2,1.2,1.6,3.8,1.6,7S4.2,12.8,7.4,12.8z'/%3e%3c/g%3e%3c/g%3e%3c/g%3e%3cg%20id='final---dec.11-2020'%3e%3cg%20id='_x30_208-our-toggle'%20transform='translate(-1275.000000,%20-200.000000)'%3e%3cg%20id='Final-Copy-2'%20transform='translate(1275.000000,%20200.000000)'%3e%3cpath%20class='st1'%20d='M22.6,0H7.4c-3.9,0-7,3.1-7,7s3.1,7,7,7h15.2c3.9,0,7-3.1,7-7S26.4,0,22.6,0z%20M1.6,7c0-3.2,2.6-5.8,5.8-5.8%20h9.9l-3.1,11.6H7.4C4.2,12.8,1.6,10.2,1.6,7z'/%3e%3cpath%20id='x'%20class='st2'%20d='M24.6,4c0.2,0.2,0.2,0.6,0,0.8l0,0L22.5,7l2.2,2.2c0.2,0.2,0.2,0.6,0,0.8c-0.2,0.2-0.6,0.2-0.8,0%20l0,0l-2.2-2.2L19.5,10c-0.2,0.2-0.6,0.2-0.8,0c-0.2-0.2-0.2-0.6,0-0.8l0,0L20.8,7l-2.2-2.2c-0.2-0.2-0.2-0.6,0-0.8%20c0.2-0.2,0.6-0.2,0.8,0l0,0l2.2,2.2L23.8,4C24,3.8,24.4,3.8,24.6,4z'/%3e%3cpath%20id='y'%20class='st3'%20d='M12.7,4.1c0.2,0.2,0.3,0.6,0.1,0.8l0,0L8.6,9.8C8.5,9.9,8.4,10,8.3,10c-0.2,0.1-0.5,0.1-0.7-0.1l0,0%20L5.4,7.7c-0.2-0.2-0.2-0.6,0-0.8c0.2-0.2,0.6-0.2,0.8,0l0,0L8,8.6l3.8-4.5C12,3.9,12.4,3.9,12.7,4.1z'/%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
Your Privacy Choices
Share and get 15% off!
Simply share this product on one of the following social networks and you will unlock 15% off!